Figure 1. Plasma levels (mean ± S. D.) of indomethacin in patients of group A (upper panel) and of group B (bottom panel) before (●) and after (■) withdrawal from the overused IPC combination (statistical differences between mean levels: * P < 0.05, Student’s t-test for paired data)

From

Pharmacokinetics of Indomethacin in Chronic Migraine Patients after Withdrawal from the Overused Combination of Indomethacin, Prochlorperazine and Caffeine

Anna Ferrari, Diego Pinetti, Daniela Gallesi, Alfio Bertolini, Grazia Sances, Emilio Sternieri

American Journal of Pharmacological Sciences. 2013, 1(5), 74-79 doi:10.12691/ajps-1-5-1